Franklin Resources Boosts Stake in Bristol Myers Squibb

Asset manager increases position in biopharmaceutical company by 3.1% in Q3

Mar. 12, 2026 at 10:34am

Got story updates? Submit your updates here. ›

Franklin Resources Inc. has increased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 3.1% during the third quarter, according to a recent 13F filing with the Securities and Exchange Commission (SEC). The fund now owns 8,702,170 shares of the biopharmaceutical company's stock, representing approximately 0.43% ownership.

Why it matters

The increased investment by Franklin Resources, one of the largest asset managers globally, signals confidence in Bristol Myers Squibb's long-term prospects. As a major shareholder, Franklin Resources' actions can influence the company's strategic direction and investor sentiment.

The details

According to the 13F filing, Franklin Resources acquired an additional 265,359 shares of Bristol Myers Squibb during the third quarter, bringing its total position to 8,702,170 shares. This represents a 3.1% increase in the fund's stake in the biopharmaceutical company.

  • The 13F filing was submitted in the third quarter of the year.

The players

Franklin Resources Inc.

A global investment management organization and one of the largest asset managers in the world, with over $1.5 trillion in assets under management.

Bristol Myers Squibb Company

A global biopharmaceutical company focused on discovering, developing, and delivering medicines for serious diseases, with a strong emphasis on oncology, hematology, immunology, and specialty areas.

Got photos? Submit your photos here. ›

The takeaway

The increased investment by Franklin Resources in Bristol Myers Squibb suggests the asset manager sees long-term value in the biopharmaceutical company's portfolio and pipeline. This move could signal growing investor confidence in Bristol Myers Squibb's ability to navigate the competitive pharmaceutical landscape and deliver returns for shareholders.